Post-ribosomal modifications of collagens include lysine hydroxylation, E amino crosslinks, and excision of procollagen extension peptides from secreted collagens.
Inherited defects of each step produce specific diseases which are also proving heterogeneous. EDS V has been described with5 and without6 lysyl oxidase deficiency. Byers et al7 have recently clearly identified lysyl oxidase deficiency in an X linked form of cutis laxa, resulting in faulty crosslink formation. EDS VI, in which scoliosis, retinal detachment, and arterial rupture complicate otherwise typical EDS, has hydroxylysine deficient8 and normal forms (McKusick, 1980, personal communication) . Procollagen peptidase deficiency in animals causes a lethal disease (dermatosparaxis)9 in which collagen fibril formation is interfered with by the persisting extensions. The puzzling benignity of the human variant'0 EDS VII has recently been explained (Steinemann, 1979, personal communication) by an amino-acid substitution at the cleavage site which allows the N terminal extension to persist.
Diseases analogous to sickle cell and haemoglobin C disease (from amino-acid substitution within the collagen molecule) are so far unidentified. Possibly single substitutions in the much larger molecule produce such insignificant changes as not to produce clinical disease or to be undetectable by electrophoresis. Amino-acid substitutions within the procollagen extension peptides do produce disease, however. EDS VII, as mentioned already, is caused by a mutation resulting in inefficient cleavage, and a recently described 01 tarda variant" has a probable substitution which allows over-glycosylation and subsequent insolubility of procollagens. We may also expect that chain termination mutations analgous to haemoglobin Constant Spring will be detected among these diseases.
When modern molecular biological techniques allow the identification of specific collagen genes for al(I), a2, and al(III), then the way is clear with cloning and restriction enzyme techniques to allow the confident intrauterine diagnosis of subjects affected by these mutations, just as is already possible in some thalassaemias.
Already (theoretically) EDS IV and the oc2 chain 01 mutant could be diagnosed by fetoscopic skin biopsy if the need and opportunity arises. The vast majority of these diseases, however, are not identifiable in this way.
These collagen abnormalities are also relevant to the more common diseases. Osteoporosis and cerebral aneurysms are obvious examples in which genetic defects similar to those mentioned above could be to blame. 
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